<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cardiovascular events are amongst the most frequent comorbidities associated with <z:hpo ids='HP_0011010'>chronic</z:hpo> pulmonary obstructe disease (COPD) </plain></SENT>
<SENT sid="1" pm="."><plain>It is believed that smoking is the main risk factor shared by both diseases </plain></SENT>
<SENT sid="2" pm="."><plain>However, there are other determining factors, such as the inflammatory system, <z:mp ids='MP_0003674'>oxidative stress</z:mp>, hpoxaemia, endotheleal dysfunction, and age itself, that could also be common aetio-pathogenic mechanisms </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">Cardiovascular disease</z:e> includes a wide spectrum of diseases, including, <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo>, <z:hpo ids='HP_0001635'>heart failure</z:hpo>, <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>, and right ventricular function </plain></SENT>
<SENT sid="4" pm="."><plain>These processes can complicate the clinical course of patients with COPD and have a clear effect on their survival </plain></SENT>
<SENT sid="5" pm="."><plain>It has been shown, from a therapeutic point of view, that the combined treatment of COPD and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> could lead to an improvement in the morbidity and mortality in patients with both diseases </plain></SENT>
<SENT sid="6" pm="."><plain>However, given that there is still insufficient evidence, its use in patients with COPD can only be recommended when there is an indication for its use, in accordance with the current clinical practice guidelines </plain></SENT>
</text></document>